213976-27-3

Upstream product

• 123-08-0 4-hydroxy-benzaldehyde 
• 172277-20-2 ethyl (2R,3S,4S)-4-(4-tert-butyldimethylsilyloxyphenyl)-4-tert-butyldiphenylsilyloxy-2-hydroxy-3-methylbutanoate 
• 172277-22-4 Acetic acid (2S,3S)-3-[4-(tert-butyl-dimethyl-silanyloxy)-phenyl]-3-hydroxy-2-methyl-propyl ester 
• 172170-16-0 (2S,3S)-1-acetoxy-3-(4-tert-butyldimethylsilyloxyphenyl)-3-tert-butyldiphenylsilyloxy-2-methylpropane 
• 172170-17-1 (2S,3S)-3-(4-tert-butyldimethylsilyloxyphenyl)-3-tert-butyldiphenylsilyloxy-2-methylpropanol 
• 172170-18-2 (2R,3S)-3-[4-(tert-Butyl-dimethyl-silanyloxy)-phenyl]-3-(tert-butyl-diphenyl-silanyloxy)-2-methyl-propionaldehyde 
• 172170-12-6 (+/-)-methyl 3-(4-tert-butyldimethylsilyloxyphenyl)-2-methyl-3-oxopropanoate 
• 120743-99-9 p-[(tert-butyldimethylsilyl)oxy]benzaldehyde 
• 213976-26-2 ethyl (2R,3S,4S)-4-(4-tert-butyldimethylsilyloxyphenyl)-4-tert-butyldiphenylsilyloxy-2-chloromethylsulfonyloxy-3-methylbutanoate 
• 213976-28-4 ethyl (2R,3S,4S)-4-(4-tert-butyldimethylsilyloxyphenyl)-4-tert-butyldiphenylsilyloxy-2-methanesulfonyloxy-3-methylbutanoate 

Downstream Products

• 172170-21-7 ethyl (2S,3S,4S)-2-azido-4-(4-tert-butyldimethylsilyloxyphenyl)-4-tert-butyldiphenylsilyloxy-3-methylbutanoate 
• 213976-31-9 2-nitrophenyl (2S,3S,4S)-2-azido-4-(4-tert-butyldimethylsilyloxyphenyl)-4-tert-butyldiphenylsilyloxy-3-methylbutanoate 
• 131068-86-5 (2S,3S,4S)-4-nitrophenyl 2-azido-4-<4-<(tert-butyldimethylsilyl)oxy>phenyl>-4-<(tert-butyldiphenylsilyl)oxy>-3-methylbutanoate 
• 127084-38-2 (2S,3S,4S)-3-buten-1-yl 2-azido-4-<4-<(tert-butyldimethylsilyl)oxy>phenyl>-4-<(tert-butyldiphenylsilyl)oxy>-3-methylbutanoate 

Relevant academic research and scientific papers

Formal total synthesis of nikkomycin B based on a lipase-catalysed hydrolysis of an acetate possessing two stereogenic centers

A stereoselective synthesis of the versatile chiral synthon possessing two stereogenic centers, (2S,3S)-11 (>99% ee) was achieved by using chemo- enzymatic method. The conversion of (2S,3s)-11 into the homochiral intermediates (2S,3S,4S)-25 and (2S,3S,4S)-27 corresponding to the N-terminal amino acid moiety of nikkomycin B(1) and their application to the formal total synthesis of nikkomycin B(1) are described.